Kwarlay.com

Navigating the News Maze with Clarity

Medicine

FDA Approves Bristol Myers Squibb’s Cobenfy for Schizophrenia

Landmark FDA approval of Cobenfy represents the first new class of drugs indicated to treat schizophrenia in decades.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *